Institute for Cancer Research

Dublin 7

0 studies enrolling now · 3 studies all time

What they study most

Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Breast Cancer

Studies at this site

• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
• Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early